ArticleFrontiers in microbiology2025
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lycopene, a vital antioxidant, can reduce oxidative damage to cells caused by reactive oxygen, prevent cancer, lower blood cholesterol levels, and mitigate cardiovascular diseases. We screened a lycopene-producing strain of the genus Method: This study was conducted to enhance lycopene production in strain A560 through a multi-stage optimization strategy, focusing on improving extraction efficiency and optimizing culture medium components. The extraction conditions were optimized by testing different solvent systems (acetone/n-hexane/ethanol), extraction temperatures, and durations. Subsequently, a uniform design (UD) was applied to systematically optimize the composition of the culture medium to maximize lycopene yield. Results: The extraction conditions were systematically optimized. A crushing duration of 4 min was identified as optimal for complete cell disruption. The most efficient solvent system was determined to be n-hexane/ethanol (2:1, Conclusion: The extraction and fermentation processes for lycopene production in
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.